On Apr. 30, 2020, Medigen Vaccine Biologics (MVC) announced its SARS-CoV-2 qPCR Kit complied with EU CE requirements, completed the EU declaration of conformity and obtained CE marking (IVD) on Apr. 24, 2020. In addition, MVC applied for specific medical devicesﾒ manufacturing in Taiwan.